These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 413471)

  • 1. Resistance against a subcutaneous Brucella challenge of mice immunized with living or dead Brucella or by transfer of immune serum.
    Pardon P
    Ann Immunol (Paris); 1977; 128(6):1025-37. PubMed ID: 413471
    [No Abstract]   [Full Text] [Related]  

  • 2. Killed vaccine in adjuvant and protection of mice against an intraperitoneal challenge of Brucella: kinetic studies.
    Pardon P; Marly J
    Ann Rech Vet; 1976; 7(4):297-305. PubMed ID: 829301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.
    Araya LN; Elzer PH; Rowe GE; Enright FM; Winter AJ
    J Immunol; 1989 Nov; 143(10):3330-7. PubMed ID: 2509555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.
    Bascoul S; Cannat A; Huguet MF; Serre A
    Immunology; 1978 Aug; 35(2):213-21. PubMed ID: 750371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen.
    Phillips M; Deyoe BL; Canning PC
    Am J Vet Res; 1989 Dec; 50(12):2158-61. PubMed ID: 2481994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of normal or immunized guinea pigs against a subcutaneous challenge of Brucella abortus.
    Pardon P; Marly J
    Ann Rech Vet; 1978; 9(3):419-25. PubMed ID: 107845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to Brucella abortus induced in mice by popliteal lymph node restricted strain 19 vaccination.
    Plommet M; Plommet AM
    Ann Rech Vet; 1989; 20(1):73-81. PubMed ID: 2494933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
    Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: immunity.
    Alton GG; Jones LM; García-Carrillo C; Trenchi A
    Am J Vet Res; 1972 Sep; 33(9):1747-51. PubMed ID: 4626469
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of exogenous recombinant interleukin-12 on immune responses and protection against Brucella abortus in a murine model.
    Lee IK; Olsen SC; Bolin CA
    Can J Vet Res; 2001 Oct; 65(4):223-8. PubMed ID: 11768128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine and serum-mediated protection against brucella infection of mouse placenta.
    Bosseray N
    Br J Exp Pathol; 1983 Dec; 64(6):617-25. PubMed ID: 6419766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
    Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
    Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Brucella cell-mediated immunity in mice vaccinated with a cell-wall fraction.
    Plommet M; Plommet AM
    Ann Rech Vet; 1987; 18(4):429-37. PubMed ID: 3451687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-Brucella immunity transferred by immune serum and that transferred by splenic lymphocytes cannot be added].
    Plommet M; Hue I; Plommet AM
    Ann Rech Vet; 1986; 17(2):169-75. PubMed ID: 3096188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of antibrucellosis vaccines using guinea pigs].
    Le Garrec Y; Pilet C; Garrido-Calderon N
    Dev Biol Stand; 1976; 31():301-7. PubMed ID: 816686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement activity of anti-brucella sera in experimental Brucella abortus infection in mice.
    Forget A; Riendeau C
    Rev Can Biol; 1977 Sep; 36(3):239-43. PubMed ID: 412235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimentally induced Brucella abortus infection in pregnant goats.
    Meador VP; Deyoe BL
    Am J Vet Res; 1986 Nov; 47(11):2337-42. PubMed ID: 3098143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
    Mallick AI; Singha H; Chaudhuri P; Nadeem A; Khan SA; Dar KA; Owais M
    Vaccine; 2007 May; 25(18):3692-704. PubMed ID: 17296251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.